Viracta Therapeutics, Inc. announced the appointment of Roger J. Pomerantz, MD, FACP, as Chairman of its Board of Directors. Dr. Pomerantz succeeds James Woody, MD, PhD, who has served as Chairman of the Board since 2015. Dr. Woody will remain a member of the Board. Prior to his appointment as Chairman, Dr. Pomerantz was appointed as an independent Director on Viracta's Board in July 2020.